11/25
07:19 am
ncna
NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/25
07:00 am
ncna
NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update
Low
Report
NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update
11/11
07:00 am
ncna
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
Medium
Report
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
9/25
04:01 pm
ncna
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
High
Report
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States